Does a high percentage of right ventricular pacing influence the incidence of paroxysmal atrial fibrillation in myotonic dystrophy type 1 patients?

Kardiologia Polska

Volumn 71, Issue 11, 2013, Pages 1147-1153

  Russo, Vincenzo ^a   Rago, Anna ^a   Papa, Andrea Antonio ^a   Politano, Luisa ^a   Golino, Paolo ^a   Russo, Maria Giovanna ^a   Calabrò, Raffaele ^a   Nigro, Gerardo ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Arrhythmias; Atrial fibrillation; Myotonic dystrophy; Pacemaker; Ventricular pacing

Indexed keywords

ADULT; ARTICLE; DUAL CHAMBER PACEMAKER; ELECTRODE; FEMALE; FOLLOW UP; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MYOTONIC DYSTROPHY;

ALGORITHMS; ATRIAL FIBRILLATION; CARDIAC PACING, ARTIFICIAL; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOTONIC DYSTROPHY; TACHYCARDIA, PAROXYSMAL;

EID: 84888226097     PISSN: 00229032     EISSN: None     Source Type: Journal    
DOI: 10.5603/KP.2013.0295     Document Type: Article

References (22)

1. Phillips MF, Harper PS. Cardiac disease in myotonic dystrophy. Cardiovasc Res, 1997; 33: 13-22.
2. Harley HG, Brook JD, Rundle SA et al. Families with myotonic dystrophy with and without cardiac involvement. Arch Intern Med, 1983; 143: 2134-2136.
3. Rotundo IL, Faraso S, De Leonibus E et al. Worsening of cardiomyopathy using deflazacort in an animal model rescued by gene therapy. PLoS One, 2011; 6: 9.
4. Lancioni A, Rotundo IL, Kobayashi YM et al. Combined deficiency of alpha and epsilon sarcoglycan disrupts the cardiac dystrophin complex. Hum Mol Genet, 2011; 20:4644-4654.
5. Nguyen HH, Wolfe JT III, Holmes DR Jr, Edwards WD. Pathology of the cardiac conduction system in myotonic dystrophy: a study of 12 cases. J Am Coll Cardiol, 1988; 11: 662-671.
6. Gregoratos G, Abrams J, Epstein AE et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: Summary article: A report of the American college of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation, 2002; 106: 2145-2161.
7. Russo V, Rago A, D'Andrea A, Politano L, Nigro G. Early onset "electrical" heart failure in myotonic dystrophy type 1 patient: the role of ICD biventricular pacing. Anadolu Kardiyol Derg, 2012; 12: 517-519.
8. Russo AD, Mangiola F, Della Bella P et al. Risk of arrhythmias in myotonic dystrophy: trial design of the RAMYD study. J Cardiovasc Med (Hagerstown), 2009; 10: 51-58.
9. Cudia P, Bernasconi P, Chiodelli R et al. Risk of arrhythmia in type I myotonic dystrophy: the role of clinical and genetic variables. J Neurol Neurosurg Psychiatry, 2009; 80: 790-793.
10. Russo V, Rago A, Politano L et al. The effect of atrial preference pacing on paroxysmal atrial fibrillation incidence in myotonic dystrophy type 1 patients: a prospective, randomized, single-bind cross-over study. Europace, 2012; 14: 486-489.
11. Lazarus A, Varin J, Babuty D et al. Long-term follow-up of arrhythmias in patients with myotonic dystrophy treated by pacing: a multicenter diagnostic pacemaker study. J Am Coll Cardiol, 2002; 40: 1645-1652.
12. Sweeney MO, Hellkamp AS, Ellenbogen KA et al. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation, 2003; 23: 2932-2937.
13. Sweeney MO, Bank AJ, Nsah E et al. Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease. N Engl J Med, 2007; 357: 1000-1008.
14. Silberbauer J, Veasey RA, Freemantle N et al. The relationship between high-frequency right ventricular pacing and paroxysmal atrial fibrillation burden. Europace, 2009; 11: 1456-1461.
15. Lazarus A, Varin J, Onnoughene Z et al. Relationships among electrophysiological findings and clinical status, heart function and extent of DNA mutation in myotonic dystrophy. Circulation, 1999; 99: 1041-1046.
16. Nigro G, Russo V, Politano L et al. Right atrial appendage versus Bachmann's bundle stimulation: a two-year comparative study of electrical parameters in myotonic dystrophy type-1 patients. Pacing Clinical Electrophysiol, 2009; 32: 1191-1196.
17. Nigro G, Russo V, Politano L et al. Does Bachmann's bundle pacing prevent atrial fibrillation in myotonic dystrophy type 1 patients? A 12 months follow-up study. Europace, 2010; 12: 1219-1223.
18. Camm AJ, Sulke N, Edvardsson N et al. Conventional and dedicated atrial overdrive pacing for the prevention of paroxysmal atrial fibrillation: the AFTherapy study. Europace, 2007; 9: 1110-1118.
19. Sulke N, Silberbauer J, Boodhoo L et al. The use of atrial overdrive and ventricular rate stabilization pacing algorithms for the prevention and treatment of paroxysmal atrial fibrillation: the Pacemaker Atrial Fibrillation Suppression (PAFS) study. Europace, 2007; 9: 790-797.
20. Veasey RA, Arya A, Freemantle N et al. The usefulness of minimal ventricular pacing and preventive AF algorithms in the treatment of PAF: the "MinVPace" study. J Interv Card Electrophysiol, 2010; 28: 51-57.
21. Sopher SM, Camm AJ. Atrial pacing to prevent atrial fibrillation? J Intervent Card Electrophysiol, 2000; 4 (suppl. I): 149-153.
22. Mehra R, Hill MRS. Prevention of atrial fibrillation/flutter by pacing techniques. In: Saksena S, Luderlitz B eds. Interventional electrophysiology: a textbook. 2nd Ed. Futura Publishing, Armonk, NY 1996: 521-540.